[PHARMA] YoY Annualized Quarter Result on 30-Jun-2020 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- -27.72%
YoY- 12.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 3,458,376 3,446,552 3,941,244 2,931,368 2,775,996 2,401,304 2,272,522 7.24%
PBT 31,070 83,920 107,536 90,412 85,448 81,354 75,854 -13.81%
Tax -20,890 -24,380 -34,104 -26,368 -27,628 -34,644 -17,836 2.66%
NP 10,180 59,540 73,432 64,044 57,820 46,710 58,018 -25.16%
-
NP to SH 9,216 56,912 73,680 64,756 57,796 45,960 56,886 -26.15%
-
Tax Rate 67.24% 29.05% 31.71% 29.16% 32.33% 42.58% 23.51% -
Total Cost 3,448,196 3,387,012 3,867,812 2,867,324 2,718,176 2,354,594 2,214,504 7.65%
-
Net Worth -137,571 406,087 357,275 357,891 518,564 519,642 541,894 -
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div - 34,058 60,200 44,409 44,299 46,767 41,484 -
Div Payout % - 59.84% 81.71% 68.58% 76.65% 101.76% 72.93% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth -137,571 406,087 357,275 357,891 518,564 519,642 541,894 -
NOSH 1,310,208 1,309,126 261,991 261,705 261,229 259,821 259,279 30.98%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 0.29% 1.73% 1.86% 2.18% 2.08% 1.95% 2.55% -
ROE 0.00% 14.01% 20.62% 18.09% 11.15% 8.84% 10.50% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 263.96 263.10 301.16 1,122.12 1,065.29 924.21 876.47 -18.12%
EPS 0.70 4.34 5.64 24.78 22.18 17.68 21.94 -43.66%
DPS 0.00 2.60 4.60 17.00 17.00 18.00 16.00 -
NAPS -0.105 0.31 0.273 1.37 1.99 2.00 2.09 -
Adjusted Per Share Value based on latest NOSH - 261,705
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 239.96 239.14 273.46 203.39 192.61 166.61 157.68 7.24%
EPS 0.64 3.95 5.11 4.49 4.01 3.19 3.95 -26.15%
DPS 0.00 2.36 4.18 3.08 3.07 3.24 2.88 -
NAPS -0.0955 0.2818 0.2479 0.2483 0.3598 0.3605 0.376 -
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 0.37 0.595 5.29 2.22 2.84 2.88 4.58 -
P/RPS 0.14 0.23 1.76 0.20 0.27 0.31 0.52 -19.63%
P/EPS 52.60 13.70 93.96 8.96 12.80 16.28 20.88 16.63%
EY 1.90 7.30 1.06 11.17 7.81 6.14 4.79 -14.27%
DY 0.00 4.37 0.87 7.66 5.99 6.25 3.49 -
P/NAPS 0.00 1.92 19.38 1.62 1.43 1.44 2.19 -
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 11/08/23 19/08/22 20/08/21 19/08/20 23/08/19 17/08/18 16/08/17 -
Price 0.42 0.595 0.925 4.42 2.66 3.11 4.19 -
P/RPS 0.16 0.23 0.31 0.39 0.25 0.34 0.48 -16.72%
P/EPS 59.71 13.70 16.43 17.83 11.99 17.58 19.10 20.91%
EY 1.67 7.30 6.09 5.61 8.34 5.69 5.24 -17.34%
DY 0.00 4.37 4.97 3.85 6.39 5.79 3.82 -
P/NAPS 0.00 1.92 3.39 3.23 1.34 1.56 2.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment